CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-40
SponsorUniversity of California, San Diego

About this trial

The goal of this randomized controlled trial is to pilot test new mobile health (mHealth) interventions to improve PrEP adherence among HIV-negative men who have sex with men (MSM) with mild to moderate methamphetamine use disorder (MUD). The CHAMPION intervention combines two mHealth tools-PrEPAPP and CBT4CBT-to address both HIV prevention and MUD treatment needs in this population. The study's specific aims are:

* To evaluate the feasibility and acceptability of the CHAMPION intervention based on treatment retention and engagement rates. * To examine the preliminary efficacy the CHAMPION intervention to improve PrEP adherence, as measured by dried blood spot (DBS) tests compared to the waitlist control group.

Eligibility criteria

Qualifiers

HIV-negative

Cis-gender male

Age 18-40 years old

Mild or moderate MUD (by DSM-5 SCID criteria)

Disqualifiers

Residing outside of San Diego or San Francisco County

Any condition that, in the principal investigator's judgment interferes with safe study participation or adherence to study procedures

Not able/willing to complete virtual/remote visits

Not willing to learn to self-collect dried blood spots using a finger stick

Trial design

Treatments tested in this trial

  • CHAMPION Intervention
  • Delayed CHAMPION Package

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of California, San Diego

Lead sponsor

University of California, San Francisco

Sponsor institution

National Institute on Drug Abuse (NIDA)

Collaborator

University of California, San Francisco

Collaborator